BP197

Hydroxycarbamide

British Pharmacopoeia (BP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 127-07-1

Synonym(S): Hydroxyurea, Hydroxycarbamide

Select a Size

Pack Size SKU Availability Price
200 MG BP197-200-MG In Stock ₹ 23,944.90

BP197 - 200 MG

₹ 23,944.90

In Stock

Quantity

1

Base Price: ₹ 23,944.90

GST (18%): ₹ 4,310.082

Total Price: ₹ 28,254.982

grade

pharmaceutical primary standard

API family

hydroxycarbamide

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceuticalpharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

NC(=O)NO

InChI

1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)

Related Products

Img

Supelco

Y0002381

CRS, European Pharmacopoeia (EP) Re...

Img

Supelco

33656

VETRANAL®, analytical standard...

Img

Supelco

49768

analytical standard...

Img

Sigma Aldrich

PHL89198

phyproof® Reference Substance...

Img

Sigma Aldrich

PHL89771

phyproof® Reference Substance...

Img

Sigma Aldrich

PHL89772

phyproof® Reference Substance...

Img

Supelco

PHR2714

Pharmaceutical Secondary Standard; ...

Img

Sigma Aldrich

PHL89218

phyproof® Reference Substance...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Hydroxycarbamide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Hydroxycarbamide Capsules
  • Biochem/physiol Actions: Anti-neoplastic. Inactivates ribonucleoside reductase by forming a free radical nitroxide that binds a tyrosyl free radical in the active site of the enzyme. This blocks the synthesis of deoxynucleotides, which inhibits DNA synthesis and induces synchronization or cell death in S-phase.
  • Packaging: Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS08

Signal Word

Danger

Hazard Statements

H340,H361

Precautionary Statements

P201 - P202 - P280 - P308 + P313 - P405 - P501

Hazard Classifications

Muta. 1B - Repr. 2

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable